Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panels [0.03%]
药物灌注系统在膀胱癌治疗中管理不良反应和程序优化的最佳实践：专家共识
Benjamin Pradere,Maarten Schuit,Félix Guerrero-Ramos et al.
Benjamin Pradere et al.
Purpose of review: To provide expert recommendations for side effect management in patients with bladder cancer receiving intravesical-drug releasing system (iDRS) treatment and for optimizing iDRS insertion procedure suc...
Cribriform carcinoma of the prostate, as aggressive as it sounds? A narrative review from the EAU section of endourology [0.03%]
筛状前列腺癌，听起来就具有侵略性吗？来自EAU经尿道内镜协会部门的叙述性评论
Nour Khalil,Guiseppe Maiolino,Massimo Valerio et al.
Nour Khalil et al.
Purpose of review: The management of localized prostate cancer (PCa) is shifting towards tissue-preserving strategies such as active surveillance and focal therapies. Intermediate-risk PCa, especially ISUP Grade Group 2 (...
Rethinking thermal safety in laser lithotripsy: a systematic review of thermal dose thresholds [0.03%]
激光碎石术中热安全性的系统评价及再思考：热剂量阈值分析
Felipe Pauchard,Alejandro Calvillo-Ramirez,Jose A Salvadó et al.
Felipe Pauchard et al.
Purpose of review: To perform a systematic review of cumulative equivalent minutes at 43 °C (CEM43) threshold considered by endourology literature to induce tissue thermal damage. ...
Bacillus Calmette-Guérin unresponsive NMIBC: novel therapies and concepts [0.03%]
卡介菌无反应NMIBC：新疗法和概念
Paolo Gontero,Jeremy Yuen-Chun Teoh
Paolo Gontero
Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer [0.03%]
新型雄激素受体通路抑制剂治疗晚期前列腺癌的毒性反应
Romain Iaxx,Diego Teyssonneau,Catherine Fallaha et al.
Romain Iaxx et al.
Purpose of review: Advanced prostate cancer (PCa) is still dependent on the androgen receptor (AR) pathway, which has led to the development of new compounds - beyond androgen receptor pathway inhibitors (ARPIs) currently...
Surgical management of benign prostatic hyperplasia in elderly and frail patients: a narrative review [0.03%]
老年和虚弱患者的良性前列腺增生的外科治疗：叙述性综述
Julien Anract,Clément Klein,Ugo Pinar et al.
Julien Anract et al.
Purpose of review: The aim of this review was to evaluate the outcomes of the various surgical techniques available today, focusing on their applicability to frail and/or elderly patients. ...
Gene-mediated therapy for BCG-unresponsive nonmuscle-invasive bladder cancer: mechanisms, clinical evidence, and practical implementation [0.03%]
卡介菌蛋白苗治疗无效的非肌层浸润性膀胱癌基因疗法：机制、临床证据及实践应用
Chris Ho-Ming Wong,David Ka-Wai Leung,Paolo Gontero et al.
Chris Ho-Ming Wong et al.
Purpose of review: Gene therapy has emerged as an attractive bladder-sparing strategy for patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer (NMIBC), addressing a thera...
Targeted therapies for Bacillus Calmette-Guerin unresponsive nonmuscle-invasive bladder cancer: a narrative review [0.03%]
博卡氏菌治疗无效的非肌层浸润性膀胱癌的靶向疗法：叙述性综述
Pierre-Etienne Gabriel,Amir Horowitz,John P Sfakianos et al.
Pierre-Etienne Gabriel et al.
Purpose of review: The purpose of this narrative review is to compile the latest available evidence on targeted therapy in the management of Bacillus Calmette-Guerin (BCG)-unresponsive nonmuscle-invasive bladder cancer (N...
Systemic immunotherapy for BCG unresponsive nonmuscle-invasive bladder cancer [0.03%]
卡介苗无应答的非肌层浸润性膀胱癌的系统免疫治疗
Karima Oualla,Mehdi Alem,Jeremy Teoh
Karima Oualla
Purpose of review: Treatment of Bacillus Calmette-Guérin (BCG)-refractory nonmuscle-invasive bladder cancer (NMIBC) is a significant clinical problem, with limited bladder-sparing strategies. The following review aims to...
Maximilian J Rabil,Ankur U Choksi,Michael S Leapman
Maximilian J Rabil
Purpose of review: Increases in wealth, scientific knowledge, and resources have contributed to unprecedented improvements in overall and urologic health over the past century. However, anthropogenic greenhouse gas emissi...